CCNE1 and breast cancer: While earlier work identified CCNE1 overexpression as a poor prognostic factor in ER+ breast cancer [13], our TCGA analysis and tissue validation specifically implicate its clinical relevance in TNB -a particularly aggressive subtype lacking targeted therapies.